Is CVS or GSK cheaper?

On trailing earnings, GSK is cheaper: CVS trades at a 45.96 P/E and GSK at 11.62.

Which has grown faster, CVS or GSK?

Over the past five years, CVS grew revenue faster — CVS at a 8.52% CAGR versus GSK at 0.63%.

Does CVS or GSK pay a bigger dividend?

CVS yields 2.55% and GSK yields 3.51% based on trailing dividends and the latest price.

Is CVS or GSK more profitable?

GSK runs the higher net margin — CVS at 0.72% versus GSK at 17.76%.

Which has been the better investment, CVS or GSK?

Over the past 10-year, GSK delivered the higher annualized total return — CVS at 4.24% versus GSK at 7.50%. Past performance doesn't predict future results.

CVS Health Corp. (CVS) vs GSK plc (GSK)

GSK leads on 12 of 16 compared metrics.

A side-by-side comparison of CVS Health Corp. and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — CVS vs GSK

growth of $100 · last 30y

CVS +937.2%GSK +98.1%CVS compounded faster

Log scale — wide-divergence pair

CVS GSK

CVS vs GSK: by the numbers

•CVS is the larger company ($133.13B vs $105.20B market cap).
•GSK trades at the lower earnings multiple (11.62 vs 45.96 P/E).
•GSK converts more revenue to profit (17.76% vs 0.72% net margin).
•CVS grew revenue faster over the past five years (8.52% vs 0.63% CAGR).
•GSK pays the higher dividend yield (3.51% vs 2.55%).

Which is better, CVS or GSK?

Metric tally: CVS 4 · GSK 12

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthCVS(faster 5Y revenue CAGR)

IncomeGSK(higher dividend yield)

QualityGSK(higher ROIC)

Metrics side by side

Valuation

Metric	CVS	GSK
P/E ratio	45.96	11.62●
Forward P/E	12.44●	13.25
P/S ratio	0.33●	2.42
P/B ratio	1.72●	3.44
PEG ratio	—	0.02
EV / EBITDA	19.20	8.62●
FCF yield	5.54%	7.87%●

Profitability

Metric	CVS	GSK
Gross margin	13.87%	72.67%●
Operating margin	1.46%	25.65%●
Net margin	0.72%	17.76%●
ROE	3.79%	25.19%●
ROIC	4.72%	16.61%●

Dividends

Metric	CVS	GSK
Dividend yield	2.55%	3.51%●
Payout ratio	190.00%	24.30%

Growth (annualized)

Metric	CVS	GSK
Revenue CAGR (5Y)	8.52%●	0.63%
EPS CAGR (5Y)	-23.89%	14.05%●
FCF CAGR (5Y)	-10.57%	-0.35%●
Total return CAGR (5Y)	7.91%	10.18%●

Frequently asked

Which is better, CVS or GSK?: It depends on your goal. value: GSK (lower P/E); growth: CVS (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 12 to 4.
Is CVS or GSK cheaper?: On trailing earnings, GSK is cheaper: CVS trades at a 45.96 P/E and GSK at 11.62.
Which has grown faster, CVS or GSK?: Over the past five years, CVS grew revenue faster — CVS at a 8.52% CAGR versus GSK at 0.63%.
Does CVS or GSK pay a bigger dividend?: CVS yields 2.55% and GSK yields 3.51% based on trailing dividends and the latest price.
Is CVS or GSK more profitable?: GSK runs the higher net margin — CVS at 0.72% versus GSK at 17.76%.
Which has been the better investment, CVS or GSK?: Over the past 10-year, GSK delivered the higher annualized total return — CVS at 4.24% versus GSK at 7.50%. Past performance doesn't predict future results.

Go deeper

Full CVS analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

CVS Health P/E ratio GSK P/E ratio CVS Health dividend yield GSK dividend yield CVS Health ROE GSK ROE CVS Health operating margin GSK operating margin CVS Health revenue growth GSK revenue growth CVS Health free cash flow GSK free cash flow

CVS Health & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.